Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis
PLoS neglected tropical diseasesPublished 20 November 2014Open access
Pamela J. Hooper, Brian Chu, Alexei Mikhailov, Eric A. Ottesen, Mark Bradley
Citations39
SJR quartileQ1
SJR score1.37
SNIP1.44
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
To assess GPELF progress in reducing the population at-risk for LF, a model based on defining reductions in risk of infection among cohorts of treated populations following each round of MDA estimates that the number of people currently atrisk of infection decreased by 46% to 789 million through 2012.
Abstract
Important progress has been made in the global efforts to eliminate LF, but significant scale-up is required over the next 8 years to reach the 2020 elimination goal.
Keywords
Immunology and MicrobiologyMedicine
Tropical Medicine & International HealthEditorial: The Global Programme to Eliminate Lymphatic Filariasis
574 Citations2000Eric A. Ottesen
ParasitologyRe-assessing the global prevalence and distribution of lymphatic filariasis
531 Citations1996E. Michael, D. A. P. Bundy +1 more
It is suggested that although the overall prevalence of filariasis cases is 2·0% globally, the disease continues to be of considerable local importance, particularly in India and Sub-Saharan Africa and is preventable based on a geographically targeted strategy for control.
PLoS neglected tropical diseasesThe Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years
336 Citations2008Eric A. Ottesen, Pamela J. Hooper +2 more
The GPELF has earlier been described as a ‘best buy’ in global health; this present tally of attributable health benefits from its first 8 years strengthens this notion considerably.
PLoS neglected tropical diseasesProgress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease
284 Citations2014K. D. Ramaiah, Eric A. Ottesen
The MDA programme has resulted in significant reduction of the LF burden and extension of MDA to all at-risk countries and to all regions within those countries where MDA has not yet reached 100% geographic coverage is imperative to further reduce the number of microfilaraemia and chronic disease cases and to reach the global target of interrupting transmission of LF by 2020.
The LancetEffect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment
187 Citations2006Reda M. R. Ramzy, M. El Setouhy +6 more
It is suggested that after five rounds of MDA filariasis is likely to have been eliminated in most endemic localities in Egypt.
Annals of Tropical Medicine and ParasitologyLymphatic filariasis elimination: progress in global programme development
164 Citations2002D. H. Molyneux, Nevio Zagaria
The GPELF has developed during an era of considerable change in international health policy, and can contribute to the relief of poverty, as LF is closely associated with low-income communities in the least developed countries and MDA is a pro-poor intervention.
New England Journal of MedicineMass Treatment to Eliminate Filariasis in Papua New Guinea
146 Citations2002Moses J. Bockarie, Daniel J. Tisch +7 more
Annual mass treatment with drugs such as diethylcarbamazine can virtually eliminate the reservoir of microfilariae and greatly reduce the frequency of clinical lymphatic abnormalities due to bancroftian filariasis.
PLoS neglected tropical diseasesThe Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)
99 Citations2010Brian Chu, Pamela J. Hooper +3 more
It is clear that the economic rate of return of the GPELF is extremely high and that this Programme continues to prove itself an excellent investment in global health.
Infectious Diseases of PovertyThe history of the elimination of lymphatic filariasis in China
57 Citations2013De-jian Sun, Deng XuLi +1 more
The ultimate goal to eliminate LF in the country was achieved in 2006 after decades of sustained efforts, close cooperation related to LF control among government departments, and active participation of endemic populations.
Transactions of the Royal Society of Tropical Medicine and HygienePlacebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India
50 Citations2001Pradeep Das, K. D. Ramaiah +5 more
Single-dose community-level treatment with DEC or ivermectin is effective in reducing W. bancrofti infection in humans and mosquitoes, and may result in total interruption of transmission after several years of control.
Emerging infectious diseasesEndpoints for Lymphatic Filariasis Programs
35 Citations2007Caroline Grady, Madsen Beau de Rochars +9 more
After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted, have implications for other LF elimination programs.
Annals of Tropical Medicine and ParasitologySignificant decrease in the prevalence of<i>Wuchereria bancrofti</i>infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria
23 Citations2005Frank O. Richards, D.D. Pam +18 more
The combination of albendazole and ivermectin appears to be superior to iver mectin alone for reducing the frequency of W. bancrofti infection in mosquitoes.
PubMedLong-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic Wuchereria bancrofti: eight years' experience in Samoa.
22 Citations1992E Kimura, G. F. S. Spears +8 more
A spaced, single-dose treatment with DEC at a 1-2-year interval seems to be an effective control measure against diurnally subperiodic W. bancrofti.
Tropical Medicine & International HealthElimination of bancroftian filariasis (<i>Wuchereria bancrofti</i>) in Santa Catarina state, Brazil
18 Citations2000Birgit Schlemper, Mário Steindel +10 more
It is confirmed that transmission of W. bancrofti was interrupted in Santa Catarina, and mass treatment appears to be more effective than treatment of microfilaraemic individuals only.
PubMedTowards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
14 Citations2002Moses J. Bockarie, Ervin Ibam +6 more
It is concluded that repeated annual single-dose community-wide treatment with DEC+IVR could lead to complete interruption of transmission and ultimately elimination of lymphatic filariasis.